Glucagon-Like-Peptide-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for their effects on weight loss and metabolic health. Emerging research suggests that GLP1-Receptor Agonists could be supportive in managing inflammatory symptoms associated with Mast Cell Activation Syndrome (MCAS). Although research is currently limited, Anna talks about what we know so far and her experience with clients taking these drugs in clinical practice.
Useful Links
Research Paper: https://www.sciencedirect.com/science/article/abs/pii/S0002962925011061
Take the Chronic Fatigue Quiz: https://app.annamarsh.co.uk/quiz-page
Instagram: https://www.instagram.com/anna__marsh_
Work with me: https://annamarsh.co.uk/work-together/
Website: http://annamarsh.co.uk/
Join the Nurturing Resilience Subscription: https://annamarsh.co.uk/nurturing-resilience/
Shownotes This episode piggybacks off the previous episode on adrenal fatigue. Here Anna discusses the difference between burnout, adrenal fatigue or exhaustion and the...
Shownotes This episode is a short and sweet menu of different testing options for your sex hormones. Anna covers blood and urine testing options...
What does life look like at the end stages of recovery? In this episode Anna shares “a day in her life” and compares this...